- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-9378
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antiviral therapy in acute viral hepatitis B: why and when ; volume:4 ; number:1 ; day:16 ; month:1 ; year:2009 ; pages:1-2 ; date:12.2009
Infectious agents and cancer ; 4, Heft 1 (16.1.2009), 1-2, 12.2009
- Urheber
-
Morelli, Giuseppe
- Beteiligte Personen und Organisationen
-
Perrella, Alessandro
Sbreglia, Costanza
Bellopede, Pasquale
Riccio, Vincenzo
Perrella, Oreste
SpringerLink (Online service)
- DOI
-
10.1186/1750-9378-4-2
- URN
-
urn:nbn:de:1111-2016072622352
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Morelli, Giuseppe
- Perrella, Alessandro
- Sbreglia, Costanza
- Bellopede, Pasquale
- Riccio, Vincenzo
- Perrella, Oreste
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies
Antiviral drugs against hepatitis C virus
Viral recognition and the antiviral interferon response
TRIM5alpha contributes to the anti-viral state
SUMOylation in Viral Replication and Antiviral Defense
Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy
Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies
Antiviral drugs against hepatitis C virus
Viral recognition and the antiviral interferon response
TRIM5alpha contributes to the anti-viral state
SUMOylation in Viral Replication and Antiviral Defense
Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy
Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies
Antiviral drugs against hepatitis C virus
Viral recognition and the antiviral interferon response
TRIM5alpha contributes to the anti-viral state
SUMOylation in Viral Replication and Antiviral Defense
Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy